therapeutic areas -


therapeutic areas endocrinology

Ferring provides human growth hormone hGH (somatropin) for the treatment of children with deficiency of the hormone and girls with Turner’s syndrome.  The somatropin product, produced by using DNA recombinant technology, is identical to human growth hormone, and the product helps these patients to achieve a normal adult height.

Ferring is committed to helping these patients by investing in research to identify and develop more user-friendly and efficient methods of treatment including all steps from identifying medical needs, developing new formulations and user friendly devices, to running clinical trials. Knowledge sharing and collaboration with international experts within the field ensures Ferring’s research is always on the forefront ethically and scientifically.

Send Email Print